Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
von Hippel-Lindau Disease
×
belzutifan
×
1 year
×
Clear all
Filters
3
NCT04924075
2026-02-24
MK-6482-015
Merck Sharp & Dohme LLC
Phase 2
Recruiting
322 enrolled
1 FDA
NCT07405164
2026-02-12
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3
Not yet recruiting
450 enrolled
NCT07167329
2025-09-11
BELIEVE-VHL
AC Camargo Cancer Center
Phase 2
Recruiting
100 enrolled